MGMT and neoplasm: A large study by Wu et al., including 131 patients with diffuse gliomas, both LGG and GBM, correlated MRI phenotype and ADC not only with molecular markers (IDH mutation, 1p/19q codeletion status, MGMT methylation) but also with tumor “aggressiveness” and survival.